2026 ICD-10-CM Diagnosis Code G12.8Other spinal muscular atrophies and related syndromes

ICD-10-CM Codes›G00–G99›G10-G14›G12

ICD-10-CM G12.8
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

G12.8 is a billable ICD-10-CM diagnosis code for other spinal muscular atrophies and related syndromes. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as bulbospinal neuronopathy. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other nervous system disorders (often hereditary or degenerative).

Code Identity

ICD-10-CM Code
G12.8
Billable Status
Yes — Valid for Submission
Code Describes
Other spinal muscular atrophies and related syndromes
Short Description
Other spinal muscular atrophies and related syndromes
Same as the full description in the CMS dataset.
Parent Code
G12
Spinal muscular atrophy and related syndromes

Code Classification

ChapterG00–G99Diseases of the nervous system
SectionG10-G14Systemic atrophies primarily affecting the central nervous system
CategoryG12Spinal muscular atrophy and related syndromes
This CodeG12.8Other spinal muscular atrophies and related syndromes

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Bulbospinal neuronopathy
  • Facioscapulohumeral spinal muscular atrophy
  • Facioscapulohumeral spinal muscular atrophy with sensory loss
  • Oculopharyngeal spinal muscular atrophy
  • Prenatal-onset spinal muscular atrophy with congenital bone fractures

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Atrophy, atrophic(of)
      • muscle, muscular (diffuse) (general) (idiopathic) (primary)
        • spinal
          • specified NEC
    • Cruveilhier's atrophy or disease

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NVS006
Other nervous system disorders (often hereditary or degenerative)
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is a group of genetic diseases that damages and kills motor neurons. Motor neurons are a type of nerve cell in the spinal cord and lower part of the brain. They control movement in your arms, legs, face, chest, throat, and tongue.

The full article covers:

  • What is spinal muscular atrophy (SMA)?
  • What are the types of spinal muscular atrophy (SMA) and what are their symptoms?
  • What causes spinal muscular atrophy (SMA)?
  • How is spinal muscular atrophy (SMA) diagnosed?
  • What are the treatments for spinal muscular atrophy (SMA)?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert G12.8 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
335.19 Spinal muscl atrophy NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About G12.8Overview

Is G12.8 (Spinal muscular atrophy and related syndromes) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other spinal muscular atrophies and related syndromes on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What is the ICD-9 equivalent of G12.8?

Under the General Equivalence Mappings, other spinal muscular atrophies and related syndromes converts to ICD-9-CM 335.19 (spinal muscl atrophy NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.